--- title: "Bayer obtains the opportunity for a Supreme Court hearing to challenge the Roundup herbicide cancer lawsuit" description: "The U.S. Supreme Court has agreed to hear Bayer's appeal regarding the lawsuits claiming that Roundup herbicide causes cancer. Bayer hopes to overturn thousands of allegations that it failed to fulfil" type: "news" locale: "en" url: "https://longbridge.com/en/news/272875912.md" published_at: "2026-01-16T20:43:47.000Z" --- # Bayer obtains the opportunity for a Supreme Court hearing to challenge the Roundup herbicide cancer lawsuit > The U.S. Supreme Court has agreed to hear Bayer's appeal regarding the lawsuits claiming that Roundup herbicide causes cancer. Bayer hopes to overturn thousands of allegations that it failed to fulfill its duty to inform through a ruling from the Supreme Court, arguing that these claims are preempted by federal law. Bayer is currently facing claims from approximately 67,000 plaintiffs who allege that the herbicide's active ingredient, glyphosate, causes cancer. Bayer's ADR rose by 5% The U.S. Supreme Court has agreed to hear Bayer AG's appeal. The company aims to challenge thousands of lawsuits alleging that its Roundup herbicide causes cancer. Bayer executives hope that the Supreme Court's ruling will help overturn thousands of cases that include failure-to-warn claims, which the company believes are preempted by federal law. Currently, Bayer still faces claims from approximately 67,000 plaintiffs who allege that long-term exposure to the main ingredient in Roundup, glyphosate, has caused them to develop cancer, while Bayer insists that the herbicide is safe. Bayer ADR rose 5%, hitting a daily high ### Related Stocks - [BAYZF.US - Bayer Aktiengesellschaft](https://longbridge.com/en/quote/BAYZF.US.md) ## Related News & Research | Title | Description | URL | |-------|-------------|-----| | FACTBOX-Major U-turns on corporate splits over the years | Kraft Heinz has halted its plans to split into two companies, joining a list of firms that have reversed major restructu | [Link](https://longbridge.com/en/news/275619741.md) | | BNP Paribas' Capza Amasses EUR1.4 Billion for Private Credit Fund | BNP Paribas' Capza Amasses EUR1.4 Billion for Private Credit Fund | [Link](https://longbridge.com/en/news/276045482.md) | | Bayer Cleared to Offer Stryax After EPA Registers Dicamba Herbicides | Bayer has received approval from the Environmental Protection Agency (EPA) to offer its Stryax herbicide, following the | [Link](https://longbridge.com/en/news/275184516.md) | | Public Storage’s Global Operations Face Rising Risks From Political Shifts and Foreign Partner Reliance | Public Storage (PSA) has identified new risks in its international operations due to political, economic, legal, and soc | [Link](https://longbridge.com/en/news/275969225.md) | | CSPC Pharmaceutical Group Limited Obtains Approval from the U.S. Food and Drug Administration to Conduct Clinical Trials in the U.S | CSPC Pharmaceutical Group Limited has received FDA approval to conduct clinical trials in the U.S. for its GLP-1/GIP rec | [Link](https://longbridge.com/en/news/276050786.md) | --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.